# OnCo record paper-pace-b-lancet-oncol-2022-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-pace-b-lancet-oncol-2022-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-pace-b-lancet-oncol-2022-update" ;
  schema:name "Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial"@en ;
  schema:description "Later report from the PACE-B trial registered as NCT01584258, in The Lancet Oncology (2022); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-pace-b-lancet-oncol-2022-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(22)00517-4>, <https://pubmed.ncbi.nlm.nih.gov/36113498/>, <https://europepmc.org/article/MED/36113498>, <https://clinicaltrials.gov/study/NCT01584258> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(22)00517-4> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Tree AC, Ostler P, van der Voet H, et al." ;
  onco:trials <https://onco.cc/trials/pace-b/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .